Skip to main content
SpringerLink
Log in

Pharmaceutical Aspects of Combination Vaccines

  • Chapter
Combination Vaccines

Abstract

In 1990, the Children’ s Vaccine Initiative (CVI) issued a challenge to vaccine developers and manufacturers (1). The challenge was to combine all childhood vaccines into a single dose, preferably oral, and to formulate the multidisease combination to be stable at ambient temperature. Heroic efforts will be required to accomplish this objective, but this is a task well worth pursuing.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mitchell, V. S., Philipose, N. M., and Sanford, J. P., eds. (1993) Children’s Vaccine Initiative, Achieving the Vision. National Academy Press, Washington, DC.

    Google Scholar 

  2. Rabinovich, N. R., McInnes, P., Klein, D. L., and Hall, B. F. (1994) Vaccine technologies: view to the future. Science 265, 1401–1404.

    Article  PubMed  CAS  Google Scholar 

  3. Centers for Disease Control and Prevention (1995) Recommended Childhood Immunization Schedule, United States, MMWR 44, 2.

    Google Scholar 

  4. Centers for Disease Control and Prevention (1997) FDA approval of a Haemophilus b conjugate combined by reconstitution with an acellular pertussis vaccine. DAMA 277 (1), 13.

    Article  Google Scholar 

  5. Eskola, J. (1996) Analysis of Haemophilus influenzae type b conjugate and diphtheriatetanus-pertussis combination vaccines. J. Infect. Dis. 174 (Suppl 3), S302–305.

    Article  PubMed  Google Scholar 

  6. Eskola, J., Olander, R. M., Hovi, T., Litmanen, L., Peltola, S., and Kayhty, H. (1996) Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccines. Lancet 348 (9043), 1688–1692.

    Article  PubMed  CAS  Google Scholar 

  7. Halperin, S. A., Barreto, L., Eastwood, B. J., Medd, L., Guasparini, R., and Mills, E. (1997) Safety and immunogenicity of an acellular pertussis diphtheria-tetanus vaccine given as a single injection with Haemophilus influenzae b conjugate vaccine. Vaccine 15, 295–300.

    Article  PubMed  CAS  Google Scholar 

  8. Greenberg, D. P., Wong, V. K., Partridge, S., Howe, B. J., and Ward, J. L. (1997) Safety and immunogenicity of a combination DTPa-hepatitis b vaccine administered to infants at 2, 4, and 6 months of age. Clin. Infec. Dis. 25, 467.

    Google Scholar 

  9. Faldella, G., Alessandroni, R., Fantini, M. P., and Salvioli, G. P. (1996) Clinical development of a combined diphtheria, tetanus acelluar pertussis and hepatitis B vaccine in Italy. J. Infect. Dis. 174 (Suppl 3), S298 - S301.

    Article  PubMed  Google Scholar 

  10. Usonis, V., Bakasenas, V., Willens, P., and Clemens, R. (1997) Feasibility study of a combined diphtheria-tetanus-acellular pertussis-hepatitis b (DTPa-HBV) vaccine, and comparison of clinical reactions and immune response with diphtheria-tetanus-acelluar pertussis (DTPa) and hepatitis b vaccines applied as mixed or injected into separate limbs. Vaccine 15, 1680–1686.

    Article  PubMed  CAS  Google Scholar 

  11. Lee, C. Y., Lee, P. I., Huang, L. M., Chen, J. M., and Chang, M. H. (1997) A simplified schedule to integrate the hepatitis B vaccine into an expanded program of immunization in epidemic countries. J. Pediatrics 130, 981–986.

    Article  CAS  Google Scholar 

  12. Halperin, S. A., Davis, H. D., Barrelo, L., Guasparini, R., Meckison, W., Humphreys, G., and Eastwood, B. J. (1977) Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen to nineteen-month-old infants. J. Pediatrics 130, 525–531.

    Article  Google Scholar 

  13. Halperin, S. A., Langley, J. M., and Eastwood, B. J. (1996) Effect of inactivated poliovirus vaccine in the antibody response to bordetella pertussis antigens when combined with diphtheria-pertussis-tetanus vaccine. Clin. Infect. Dis. 22, 59–62.

    Article  PubMed  CAS  Google Scholar 

  14. Begue, P., Stagnara, J., Vie-Le-Sage, F., Bernard, J. C., Zerri, B., and Abitol, V. (1997) Immunogenicity and reactogenicity of a booster dose of diphtheria, tetanus, acelluar pertussis and inactivated poliomyelitis vaccines given concurrently with haemophilus type b conjugate vaccine or as pentavalent vaccine. Ped. Infect. Dis. J. 16, 787–794.

    Article  CAS  Google Scholar 

  15. Schneerson, R. (1997) Immunogenicity and safety of mixed DTP/IPV/Hib vaccine. Lancet 349, 881, 882.

    Google Scholar 

  16. Zepp, F., Schmitt, H. J., Kaufhold, A., Schuind, A., Knuf, M., Hubermehl, P., Meyer, C., Bogarts, H., Slavoui, M., and Clemens, R. (1997) Evidence for induction of polysaccharide specific B-cell-memory in the first year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine. Eur. J. Ped. 156, 18–24.

    Article  CAS  Google Scholar 

  17. Marketing agreement signed for pediatric product line. Vaccine Weekly,October 28, 1996 (D. J. DeNoon, Sr. Ed.). p. 12.

    Google Scholar 

  18. West, P. J., Hesley, T. M., Joans, L. C., Feeley, L. K., Bird, S. R., Burke, P., and Sadoff, J. C. (1997) Safety and immunogenicity of a bivalent Haemophilus influenzae Type b/hepatitis b vaccine in healthy infants. Hib-HB vaccine study group. Ped. Infect. Dis. J. 16, 593–599.

    Article  CAS  Google Scholar 

  19. Fessard, C. and Keystone, J. S. (1997) A role for combined vaccination against hepatitis A and B? Int. J. Infect. Dis. 1, 226–232.

    Article  Google Scholar 

  20. White, C. J., Stinson, D., Steahle, B., Cho, I., Matthews, H., Ngai, A., Keller, P., Eiden, J., and Kuter, B. (1997) Measles, mumps, rubella and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. measles, mumps, rubella, varicella vaccine study group. Clin. Infect. Dis. 24, 925–931.

    Article  PubMed  CAS  Google Scholar 

  21. Lang, J., Duong, G. H., Nguyen, V. G., Le, T. T., Nguyen, C. V., Kesmedjian, V., and Plotkin, S. A. (1997). Randomized feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants. Lancet 349, 1663–1665.

    Article  PubMed  CAS  Google Scholar 

  22. FDC Reports, Connaught TriHIBit additional Haemophilus antibody data submitted to FDA for analysis to adress unresolved question concerning suppression. The Pink Sheet, June 16, 1997, pp. 13–14.

    Google Scholar 

  23. Williams, J. C., Goldenthal, K. L., Bums, D. R., and Lewis, Jr., B. P., eds., (1995) Combined vaccines and simultaneous administration: current issues and perspectives from conference sponsored by CBER, USFDA, NIH, CDC, WHO in Bethesda, MD July 28–30, 1993. Ann. NYAcad. Sci. 754, xi—xv.

    Google Scholar 

  24. Center for Biologic Evaluation and Research (1997) Guidance for industry for the evaluation of combination vaccines for preventable diseases: production, testing and clinical studies. April. Federal Register 62, 17,624–17, 625.

    Google Scholar 

  25. European Vaccines Manufacturers (1994) Combined vaccines for Europe; pharmaceutical, egulatory and policy-making aspects. Biologicals 22, 297–436.

    Google Scholar 

  26. Committee for Proprietary Medicinal Products (1997) Pharmaceutical, pre-clinical and regulatory aspects of combined vaccines. Draft #6. March 26, 1997. Presented at Biotechnology Working Party Meeting on May 6–7, 1997.

    Google Scholar 

  27. Corbel, M. J. (1994) Control testing of combined vaccines: a consideration of potential problems and approaches. Biologicals 22, 353–360.

    Article  PubMed  CAS  Google Scholar 

  28. International Conference on Harmonization Guidelines. Guidance on Non-Clinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals. Federal Register November 25, 1997, 62,922.

    Google Scholar 

  29. Plotkin, S. A. (1994) Problems in the choice of combined vaccines for Europe. Biologicals 22, 411–414.

    Article  PubMed  CAS  Google Scholar 

  30. Schaack, J-C. (1997) Harmonization of vaccination policy. Biologicals 25, 243–245.

    Article  PubMed  CAS  Google Scholar 

  31. World Health Organization (1996) State of the world’s vaccine and immunization, WHO, Geneva, Switzerland, p. 29.

    Google Scholar 

  32. Schlesinger, Y., Granoff, D. M., and the Vaccine Study Group (1992). Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae Type b conjugate vaccines. JAMA 267, 1489–1494.

    Article  Google Scholar 

  33. Clements, M. L. (1995) Combination live respiratory virus vaccines. Ann. NYAcad. Sci. 754, 351–355.

    Article  CAS  Google Scholar 

  34. Olin, P. (1995) Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: pertussis vaccination. Ann. NYAcad. Sci. 754, 273–277.

    Article  CAS  Google Scholar 

  35. Plotkin, S. A. and Fletcher, M. A. (1996) Combination vaccines and immunization visits. Ped. Infect. Dis. J. 15, 103–105.

    Article  CAS  Google Scholar 

  36. Paradiso, P. R., Hogerman, D. A., Madore, D. V., Keyserling, H., King, J., Reisinger, K. S., Blatter, M. M., Rothstein, E., Bernstein, H. H., Pennridge Pediatric Associates, and Hackell, J. (1993) Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants. Pediatrics 92, 827–832.

    PubMed  CAS  Google Scholar 

  37. Clemens, J. D., Ferreccio, C., Levine, M. M., Horowitz, I., Rao, M. R., Eng, M., Edwards, K. M., and Fritzell, B. (1992) Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheriatetanus-pertussis vaccine. JAMA 267, 673–678.

    Article  PubMed  CAS  Google Scholar 

  38. Sabin, A. B. (1959) Recent studies and field tests with a live attenuated poliovirus vaccine, in Live Poliovirus Vaccines: Papers Presented and Discussions Held at the First International Conference on Live Poliovirus Vaccines. Pan American Sanitary Bureau (Special Publication No. 44 ). Washington, DC, 14–38.

    Google Scholar 

  39. Lee, C. J. (1983) The quantitative immunochemical determination of pneumococcal and meningococcal capsular polysaccharides by light scattering rate nephelometry. J. Biol. Stand. 11, 55–64.

    Article  PubMed  CAS  Google Scholar 

  40. Bevilacqua. J. M., Young, L., Chiu, S. W., Sparkes, J. D., and Kreeftenberg, J. G. (1996) Rat immunogenicity assay of inactivated poliovirus. Dev. Biol. Stand. 86, 121–127.

    Google Scholar 

  41. Blackwelder, W. C. (1995) Similarity/equivalence trials for combination vaccines. Ann. NY Acad. Sci. 754, 321–328.

    Article  PubMed  CAS  Google Scholar 

  42. Corkill, J. M. (1967). The stability of the components in DPT-poliomyelitis and DPTpoliomyelitis-measles vaccines. Symposia Series in Immunobiological Standardization. Vol. 7, Basel, Karger, pp. 165–178.

    Google Scholar 

  43. Usonis, V., Bakasenas, V., Taylor, D., and Vandepapeliere, P. (1996) Immunogenicity and reactogenicity of a combined DTPw-hepatitis B vaccine in Lithuanian infants. Eur. J. Pediatr. 155, 189–193.

    Article  PubMed  CAS  Google Scholar 

  44. Gardner, R. A. and Pittman, M. (1965). Relative stability of pertussis vaccine preserved with merthiolate, benzethonium chloride, or the parabens. Appl. Microbiol. 13, 564–569.

    PubMed  CAS  Google Scholar 

  45. Davisson, E. O., Powell, H. M., MacFarlane, J. O., Hodgson, R., Stone, R. L., and Culbertson, C. G. (1956). The preservation of poliomyelitis vaccine with stabilized merthiolate. J. Lab. Clin. Med. 47, 8–19.

    PubMed  CAS  Google Scholar 

  46. Sawyer, L. A., McInnis, J., Patel, A., Horne, A. D., and Albrecht, P. (1994) Deleterious effect of thimerosal on the potency of inactivated poliovirus vaccine. Vaccine 12, 851–856.

    Article  PubMed  CAS  Google Scholar 

  47. Eskola, J., Olander, R.-M., Litmanen, L., Saarinen, L., Bogaerts, H., and Kayhty, H. (1995) Hib antibody response after two doses of combined DTPa-Hib conjugate vaccine as compared to separate injections. Interscience Conference on Antimicrobial Agents and Chemotherapy, 160. Abstract No. G11.

    Google Scholar 

  48. Corbel, M. J. (1996) Reasons for instability of bacterial vaccines. Dev. Biol. Stand. 87, 113–124.

    PubMed  CAS  Google Scholar 

  49. Vogel, F. R. (1995) Immunologic adjuvants for modern vaccine formulations. Ann. NY Acad. Sci. 754, 153–160.

    Article  PubMed  CAS  Google Scholar 

  50. Gupta, R. K. (1998) Aluminum compounds as vaccine adjuvants. Adv. Drug Del. Rev. 32, 155–172.

    Article  CAS  Google Scholar 

  51. Chang, M. F., White, J. L., Nail, S. L., and Hem, S. L. (1997) Role of the electrostatic attractive force in the adsorption of proteins by aluminum hydroxide adjuvant. PDA J. Pharm. Sci. Technol. 51 (1), 25–29.

    PubMed  CAS  Google Scholar 

  52. Ellis, R. W. and Douglas, R. G., Jr. (1994) Combination vaccines. Int. J. Technol. Assess. Health Care 10, 185–192.

    Article  PubMed  CAS  Google Scholar 

  53. Ellis, R. W. and Brown, K. R. (1997) Combination vaccines, in Advances in Pharmacology, August, J. T., Anders, M. W., Murad, F., and Coyle, J. T. (eds.), Academic, San Diego, CA, pp. 393–423.

    Google Scholar 

  54. Grabenstein, J. D. (1990) Drug interactions involving immunologic agents. Part I. Vaccine-vaccine, vaccine-immunoglobin, and vaccine-drug interactions, DICP Ann. Pharmacother. 24, 67–81.

    CAS  Google Scholar 

  55. Gallili, G. E. (1990) Use of combined viral vaccines, in Viral Vaccines ( Mizrahi, A., ed.), Wiley-Liss, New York, NY, pp. 147–157.

    Google Scholar 

  56. Andre, F. E. and Peetermans, J. (1986) Effect of simultaneous administration of live measles vaccine on the “take rate” of live mumps vaccine. Dev. Biol. Stand. 65, 101–107.

    PubMed  CAS  Google Scholar 

  57. Meyer, H. M., Jr., Hopps, H. E., Bernheim, B. C., and Douglas, R. D. (1967) Combined measles-smallpox and other vaccines, in First International Conference on Vaccines Against Viral and Rickettsia Diseases in Man, Pan American Health Organization (Scientific Publication No. 147 ). Washington, DC, pp. 336–342.

    Google Scholar 

  58. Insel, R. A. (1995) Potential alterations in immunogenicity by combining or simultaneously administering vaccine components. Ann. NYAcad. Sci. 754, 35–47.

    Article  CAS  Google Scholar 

  59. Germain, R. N. (1995) The biochemistry and cell biology of antigen presentation by MHC Class I and Class II molecules. Implications for development of combination vaccines. Ann. NYAcad. Sci. 754, 114–125.

    Article  CAS  Google Scholar 

  60. Melnick, J. L. and Wallis, C. (1963) The effect of pH on thermal stabilization of oral polio virus by magnesium chloride. Proc. Soc. Exp. Biol. Med. 112, 894–897.

    PubMed  CAS  Google Scholar 

  61. Volkin, D. B., Burke, C. J., Sanyal, G., and Middaugh, C. R. (1996) Analysis of vaccine stability. Dey. Biol. Stand. 87, 135–142.

    CAS  Google Scholar 

  62. Federal Register,Tuesday, September 30, 1997, Department of Health and Human Services. Natural rubber-containing medical devices; user labeling, pp. 51,021–51,030.

    Google Scholar 

  63. Maleckar, J., Fosseco, S., and Katkocin, D. (1996) Factors affecting the ability of experimental vaccines to protect guinea pigs against lethal challenge with diphtheria toxin. Presented at WHO/IABS/NIBSC International Meeting on the Control and Standardization of Acellular Pertussis Vaccines. NIBSC, Potters Bar, Hertfordshire, UK, September 26–27.

    Google Scholar 

  64. Brown, K. R. (1995) Industry perspective on clinical trial issues for combination vaccines. Ann. NYAcad. Sci. 754, 241–249.

    Article  CAS  Google Scholar 

  65. Mercer Management Consulting Report on the United States Vaccine Industry to the U. S. Dept. of Health and Human Services, June 14, 1995.

    Google Scholar 

  66. Nail, S. L., White, J. L., and Hern, S. L. (1976) Structure of aluminium hydroxide gel I. Initial precipitate. J. Pharm. Sci. 65, 1188–1191.

    Article  PubMed  CAS  Google Scholar 

  67. Ada, G. (1994) Combination vaccines: present practices and future possibilities. Biologicals 22, 329–331.

    Article  PubMed  CAS  Google Scholar 

  68. Daum, R. S., Jain, A., and Goldstein, K. P. (1995) Combination vaccines: some practical considerations. Ann. NYAcad. Sci. 754, 383–387.

    Article  CAS  Google Scholar 

  69. Peetermans, J. (1996) Factors affecting the stability of viral vaccines. Dey. Biol. Stand. 87, 97–101.

    CAS  Google Scholar 

  70. Peetermans, J., Colinet, G., Stephenne, J., and Bouillet, A. (1978) Stability of freeze-dried and reconstituted measles vaccine. Dev. Biol. Stand. 41, 259–264.

    PubMed  CAS  Google Scholar 

  71. Needleless Injections from PowderJect (1997) SCRIP No. 2232, P. J. B. Publications, Ltd. May 16, p. 13.

    Google Scholar 

  72. Fox, J. L. (1997) Education seen as key in bringing vaccines to adults. ASM News 63, 29–33.

    Google Scholar 

  73. Walker, R. I. (1994) New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 12, 387–397.

    Article  PubMed  CAS  Google Scholar 

  74. Eskola, J. (1994) Epidemiological views into possible components of paediatric combined vaccines in 2015. Biologicals 22, 323–327.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Dennis M. Katkocin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chia-Lung Hsieh
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Vaccine Development, BioChem Pharma, Inc., Northborough, MA, USA

    Ronald W. Ellis PhD (Vice-President, General Manager) (Vice-President, General Manager)

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Katkocin, D.M., Hsieh, CL. (1999). Pharmaceutical Aspects of Combination Vaccines. In: Ellis, R.W. (eds) Combination Vaccines. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-265-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-265-4_3

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-4802-4

  • Online ISBN: 978-1-59259-265-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation